Product Code: GVR-4-68039-023-5
Point Of Care CT Imaging Market Growth & Trends:
The global point of care CT imaging market size is expected to reach USD 327.8 million by 2030, according to a new report by Grand View Research Inc., expanding at a CAGR of 5.59% from 2024 to 2030. The growing prevalence of neurological conditions including traumatic brain injury and brain tumor is expected to drive the market growth. Additionally, the increasing burden due to COVID-19 is leading people to opt for PoC Computed Tomography (CT) imaging to identify the problem. As the demand for the PoC CT imaging is increasing outpatient settings such as Ambulatory Surgery Centers (ASCs), hospitals, and clinics are widely installing the devices.
A large number of clinical trial studies are being conducted on PoC computed tomography imaging devices to understand the effectiveness and efficiency of the device in diagnosing various diseases. Many research centers and institutes, therefore, are installing the devices for conducting these studies. Furthermore, market players are forming alliances to enhance knowledge regarding PoC computed tomography imaging by support educational groups at research institutions.
Patients seeking PoC diagnostic devices prefer outpatient settings over the hospital to avoid long wait time and extra hospital-associated expenses. Therefore, market players to provide PoC computed tomography imaging in these settings are developing compact devices that can be easily accommodated and accessed. Many players are adding mobility as well to the compact devices so that these devices can be carried to different departments and locations, especially, where the need for COVID-19 diagnosis is high.
Market players are forming strategic alliances with various distributors to provide advanced PoC computed tomography imaging devices for COVID-19 diagnosis. In February 2020, NeuroLogica in assistance with Chinese distributor Chindex, is distributing the BodyTomPoC CT scanner in China for COVID-19 diagnosis. Moreover, these players are also creating digital platforms to enhance the access images captured by PoC computed tomography imaging devices for consultation.
Point Of Care CT Imaging Market Report Highlights:
- The full-sized PoC CT scanners segment held the largest share in 2023 due to the presence of a large patient pool and the development of weight-bearing computed tomography scanners
- The compact PoC CT scanners segment is expected to drive the market during the forecast period due to the growing pandemic situation and increasing adoption of computed tomography imaging in outpatient settings
- The neurology application segment held the largest share in 2023 owing to the increasing number of neurological disorder cases
- The respiratory application segment is expected to grow at the fastest rate during the forecast period owing to the increasing respiratory problems faced during the pandemic and growing demand for early diagnosis due to COVID-19
- The hospital segment held the largest revenue share in 2023 owing to the increasing installation of advanced PoC computed tomography imaging devices for enhanced diagnosis
- Ambulatory surgery centers (ASCs) is expected to grow at the fastest rate during the forecast period due to the easy availability of PoC computed tomography imaging in these centers at affordable price
- In 2023, North America dominated the market and accounted for the largest revenue share owing to the rising adoption of advanced testing devices in the region and the presence of major market players in the region
- In Asia Pacific, the market is expected to grow at the fastest growth rate during the forecast period mainly due to increasing strategic alliances between players and distributors to provide PoC computed tomography imaging in the region.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End-use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End-use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Point of Care CT Imaging Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Technological advancements
- 3.2.1.2. Increasing demand for point-of-care diagnostics
- 3.2.1.3. Aging population
- 3.2.1.4. Growing prevalence of chronic diseases
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost of devices
- 3.2.2.2. Regulatory and reimbursement challenges
- 3.3. Point of Care CT Imaging Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Point of Care CT Imaging Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Point of Care CT Imaging Product Market Movement Analysis
- 4.3. Global Point of Care CT Imaging Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Compact CT scanners
- 4.4.1. Compact CT scanners market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Full-sized CT scanners
- 4.5.1. Full-sized CT scanners market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Point of Care CT Imaging Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Point of Care CT Imaging Application Market Movement Analysis
- 5.3. Global Point of Care CT Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Neurology
- 5.4.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Musculoskeletal
- 5.5.1. Musculoskeletal market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6. Respiratory
- 5.6.1. Respiratory market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.7. ENT
- 5.7.1. ENT market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.8. Others
- 5.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Point of Care CT Imaging Market: End-use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Point of Care CT Imaging End-use Market Movement Analysis
- 6.3. Global Point of Care CT Imaging Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
- 6.4. Hospitals
- 6.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.5. Ambulatory Surgery Centers
- 6.5.1. Ambulatory surgery centers market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6. Clinics
- 6.6.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.7. Others
- 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Point of Care CT Imaging Market: Regional Estimates & Trend Analysis By Product, Application, End-use
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.5. North America
- 7.5.1. U.S.
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Competitive scenario
- 7.5.1.3. Regulatory framework/ reimbursement structure
- 7.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.2. Canada
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Competitive scenario
- 7.5.2.3. Regulatory framework/ reimbursement structure
- 7.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.3. Mexico
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Competitive scenario
- 7.5.3.3. Regulatory framework/ reimbursement structure
- 7.5.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6. Europe
- 7.6.1. Regulatory framework/ reimbursement structure
- 7.6.2. UK
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Competitive scenario
- 7.6.2.3. Regulatory framework/ reimbursement structure
- 7.6.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.3. Germany
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Competitive scenario
- 7.6.3.3. Regulatory framework/ reimbursement structure
- 7.6.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.4. France
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Competitive scenario
- 7.6.4.3. Regulatory framework/ reimbursement structure
- 7.6.4.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.5. Italy
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Competitive scenario
- 7.6.5.3. Regulatory framework/ reimbursement structure
- 7.6.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.6. Spain
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Competitive scenario
- 7.6.6.3. Regulatory framework/ reimbursement structure
- 7.6.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.7. Norway
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Competitive scenario
- 7.6.7.3. Regulatory framework/ reimbursement structure
- 7.6.7.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.8. Sweden
- 7.6.8.1. Key country dynamics
- 7.6.8.2. Competitive scenario
- 7.6.8.3. Regulatory framework/ reimbursement structure
- 7.6.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.9. Denmark
- 7.6.9.1. Key country dynamics
- 7.6.9.2. Competitive scenario
- 7.6.9.3. Regulatory framework/ reimbursement structure
- 7.6.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Regulatory framework/ reimbursement structure
- 7.7.2. Japan
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Competitive scenario
- 7.7.2.3. Regulatory framework/ reimbursement structure
- 7.7.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7.3. China
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive scenario
- 7.7.3.3. Regulatory framework/ reimbursement structure
- 7.7.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7.4. India
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Competitive scenario
- 7.7.4.3. Regulatory framework/ reimbursement structure
- 7.7.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7.5. Australia
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Competitive scenario
- 7.7.5.3. Regulatory framework/ reimbursement structure
- 7.7.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7.6. South Korea
- 7.7.6.1. Key country dynamics
- 7.7.6.2. Competitive scenario
- 7.7.6.3. Regulatory framework/ reimbursement structure
- 7.7.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7.7. Thailand
- 7.7.7.1. Key country dynamics
- 7.7.7.2. Competitive scenario
- 7.7.7.3. Regulatory framework/ reimbursement structure
- 7.7.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Regulatory framework/ reimbursement structure
- 7.8.2. Brazil
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Competitive scenario
- 7.8.2.3. Regulatory framework/ reimbursement structure
- 7.8.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.8.3. Argentina
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Competitive scenario
- 7.8.3.3. Regulatory framework/ reimbursement structure
- 7.8.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.9. MEA
- 7.9.1. Regulatory framework/ reimbursement structure
- 7.9.2. South Africa
- 7.9.2.1. Key country dynamics
- 7.9.2.2. Competitive scenario
- 7.9.2.3. Regulatory framework/ reimbursement structure
- 7.9.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.9.3. Saudi Arabia
- 7.9.3.1. Key country dynamics
- 7.9.3.2. Competitive scenario
- 7.9.3.3. Regulatory framework/ reimbursement structure
- 7.9.3.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.9.4. UAE
- 7.9.4.1. Key country dynamics
- 7.9.4.2. Competitive scenario
- 7.9.4.3. Regulatory framework/ reimbursement structure
- 7.9.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.9.5. Kuwait
- 7.9.5.1. Key country dynamics
- 7.9.5.2. Competitive scenario
- 7.9.5.3. Regulatory framework/ reimbursement structure
- 7.9.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Key company market share analysis, 2023
- 8.4. Company Position Analysis
- 8.5. Company Categorization (Emerging Players, Innovators and Leaders
- 8.6. Company Profiles
- 8.6.1. Xoran Technologies, LLC
- 8.6.1.1. Company overview
- 8.6.1.2. Financial performance
- 8.6.1.3. Product benchmarking
- 8.6.1.4. Strategic initiatives
- 8.6.2. CurveBeam
- 8.6.2.1. Company overview
- 8.6.2.2. Financial performance
- 8.6.2.3. Product benchmarking
- 8.6.2.4. Strategic initiatives
- 8.6.3. Planmed
- 8.6.3.1. Company overview
- 8.6.3.2. Financial performance
- 8.6.3.3. Product benchmarking
- 8.6.3.4. Strategic initiatives
- 8.6.4. NeuroLogica Corp.
- 8.6.4.1. Company overview
- 8.6.4.2. Financial performance
- 8.6.4.3. Product benchmarking
- 8.6.4.4. Strategic initiatives
- 8.6.5. Siemens Healthcare GmbH
- 8.6.5.1. Company overview
- 8.6.5.2. Financial performance
- 8.6.5.3. Product benchmarking
- 8.6.5.4. Strategic initiatives
Chapter 9. Analyst Perspective